Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , |
Tipo de documento: | preprint |
Idioma: | spa |
Título da fonte: | SciELO Preprints |
Texto Completo: | https://preprints.scielo.org/index.php/scielo/preprint/view/681 |
Resumo: | COVID-19 pandemic is challenging Latin American health systems, which could benefit from information to make appropriate decisions in contexts of constrained health resources.Objective: to evaluate, in adult patients with suspected mild clinical forms of COVID-19, the clinical effectiveness (life expectancy) and resource consumption (days of hospitalization) of different management strategies.Methods: stochastic decision tree comparing the conventional strategy recommended by WHO - PAHO (diagnostic test for COVID-19 and hospitalization of patients testing positive) versus two alternative strategies (immediate addition of a prognostic test with hospitalization according to its result, or follow-up with hospitalization only in case of clinical deterioration).Results: the alternative management strategies showed expected clinical utility similar to the conventional strategy in 80 years-old base cases, and slightly lower in 60 years- and 40 years-old base cases, with lower consumption of hospitalization days. In sensitivity analysis, alternative strategies comparatively improved their expected clinical utility given a lower sensitivity of the diagnostic test or a higher ability of the follow-up to detect clinical worsening.Conclusions: in cases of suspected COVID-19 without pneumonic infiltrate or signs of severity, alternative strategies can be considered to avoid hospitalization for the majority of patients, especially if efficient follow-up modalities can be implemented. This information is valuable for health decision-makers, to carefully weight clinical and epidemiological elements and design locally feasible strategies. |
id |
SCI-1_2a2a9671189c006dd7f02374874b60a0 |
---|---|
oai_identifier_str |
oai:ops.preprints.scielo.org:preprint/681 |
network_acronym_str |
SCI-1 |
network_name_str |
SciELO Preprints |
repository_id_str |
|
spelling |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision ModelEstrategias de manejo clínico de casos leves de COVID-19 en América Latina: Modelo de decisiónInfecciones por coronavirusModelos teóricosAsignación de recursosCoronavirus infectionsTheoretical modelsResource allocationCOVID-19 pandemic is challenging Latin American health systems, which could benefit from information to make appropriate decisions in contexts of constrained health resources.Objective: to evaluate, in adult patients with suspected mild clinical forms of COVID-19, the clinical effectiveness (life expectancy) and resource consumption (days of hospitalization) of different management strategies.Methods: stochastic decision tree comparing the conventional strategy recommended by WHO - PAHO (diagnostic test for COVID-19 and hospitalization of patients testing positive) versus two alternative strategies (immediate addition of a prognostic test with hospitalization according to its result, or follow-up with hospitalization only in case of clinical deterioration).Results: the alternative management strategies showed expected clinical utility similar to the conventional strategy in 80 years-old base cases, and slightly lower in 60 years- and 40 years-old base cases, with lower consumption of hospitalization days. In sensitivity analysis, alternative strategies comparatively improved their expected clinical utility given a lower sensitivity of the diagnostic test or a higher ability of the follow-up to detect clinical worsening.Conclusions: in cases of suspected COVID-19 without pneumonic infiltrate or signs of severity, alternative strategies can be considered to avoid hospitalization for the majority of patients, especially if efficient follow-up modalities can be implemented. This information is valuable for health decision-makers, to carefully weight clinical and epidemiological elements and design locally feasible strategies.La pandemia COVID-19 desafía los sistemas de salud de Latinoamérica, que podrían beneficiarse de información para tomar decisiones apropiadas, en contextos de escasez de recursos sanitarios.Objetivo: evaluar, en pacientes adultos con sospecha de formas clínicas leves de COVID-19, la efectividad clínica (expectativa de vida) y el consumo de recursos (días de hospitalización) de distintas estrategias de manejo. Métodos: árbol de decisión estocástico, comparando la estrategia convencional recomendada por OMS - OPS (prueba diagnóstica para COVID-19 y hospitalización ante resultado positivo) versus dos estrategias alternativas (agregado inmediato de una prueba pronóstica con hospitalización según ese resultado, y seguimiento con hospitalización sólo ante empeoramiento clínico). Resultados: las estrategias de manejo alternativas mostraron utilidad clínica esperada similar a la estrategia convencional en casos base de 80 años de edad, y ligeramente inferior en casos base de 60 años y 40 años de edad, con menor consumo de días de hospitalización. En el análisis de sensibilidad, las estrategias alternativas mejoraron comparativamente su utilidad clínica esperada si la sensibilidad de la prueba diagnóstica fuera menor o la capacidad del seguimiento para detectar empeoramiento clínico fuera mayor. Conclusiones: ante casos sospechosos de COVID-19 sin infiltrado neumónico ni signos de gravedad, pueden considerarse estrategias que eviten la hospitalización de la mayoría de los pacientes, en especial si pueden implementarse modalidades de seguimiento eficientes. Esta información es valiosa para los decisores en salud, para analizar ponderadamente elementos clínicos y epidemiológicos y diseñar estrategias factibles localmente.SciELO PreprintsSciELO PreprintsSciELO Preprints2020-06-02info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/68110.1590/SciELOPreprints.681spahttps://preprints.scielo.org/index.php/scielo/article/view/681/899Copyright (c) 2020 Carlos Boissonnet, Mariano Giorgi, Lucila Carosella, Carola Brescacín, Jerónimo Pissinis, Javier Guettahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBoissonnet, Carlos P.Giorgi, Mariano A.Carosella, LucilaBrescacín, CarolaPissinis, JerónimoGuetta, Javier N.reponame:SciELO Preprintsinstname:SciELOinstacron:SCI2020-05-31T20:11:11Zoai:ops.preprints.scielo.org:preprint/681Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2020-05-31T20:11:11SciELO Preprints - SciELOfalse |
dc.title.none.fl_str_mv |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model Estrategias de manejo clínico de casos leves de COVID-19 en América Latina: Modelo de decisión |
title |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model |
spellingShingle |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model Boissonnet, Carlos P. Infecciones por coronavirus Modelos teóricos Asignación de recursos Coronavirus infections Theoretical models Resource allocation |
title_short |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model |
title_full |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model |
title_fullStr |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model |
title_full_unstemmed |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model |
title_sort |
Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model |
author |
Boissonnet, Carlos P. |
author_facet |
Boissonnet, Carlos P. Giorgi, Mariano A. Carosella, Lucila Brescacín, Carola Pissinis, Jerónimo Guetta, Javier N. |
author_role |
author |
author2 |
Giorgi, Mariano A. Carosella, Lucila Brescacín, Carola Pissinis, Jerónimo Guetta, Javier N. |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Boissonnet, Carlos P. Giorgi, Mariano A. Carosella, Lucila Brescacín, Carola Pissinis, Jerónimo Guetta, Javier N. |
dc.subject.por.fl_str_mv |
Infecciones por coronavirus Modelos teóricos Asignación de recursos Coronavirus infections Theoretical models Resource allocation |
topic |
Infecciones por coronavirus Modelos teóricos Asignación de recursos Coronavirus infections Theoretical models Resource allocation |
description |
COVID-19 pandemic is challenging Latin American health systems, which could benefit from information to make appropriate decisions in contexts of constrained health resources.Objective: to evaluate, in adult patients with suspected mild clinical forms of COVID-19, the clinical effectiveness (life expectancy) and resource consumption (days of hospitalization) of different management strategies.Methods: stochastic decision tree comparing the conventional strategy recommended by WHO - PAHO (diagnostic test for COVID-19 and hospitalization of patients testing positive) versus two alternative strategies (immediate addition of a prognostic test with hospitalization according to its result, or follow-up with hospitalization only in case of clinical deterioration).Results: the alternative management strategies showed expected clinical utility similar to the conventional strategy in 80 years-old base cases, and slightly lower in 60 years- and 40 years-old base cases, with lower consumption of hospitalization days. In sensitivity analysis, alternative strategies comparatively improved their expected clinical utility given a lower sensitivity of the diagnostic test or a higher ability of the follow-up to detect clinical worsening.Conclusions: in cases of suspected COVID-19 without pneumonic infiltrate or signs of severity, alternative strategies can be considered to avoid hospitalization for the majority of patients, especially if efficient follow-up modalities can be implemented. This information is valuable for health decision-makers, to carefully weight clinical and epidemiological elements and design locally feasible strategies. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-06-02 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/preprint info:eu-repo/semantics/publishedVersion |
format |
preprint |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://preprints.scielo.org/index.php/scielo/preprint/view/681 10.1590/SciELOPreprints.681 |
url |
https://preprints.scielo.org/index.php/scielo/preprint/view/681 |
identifier_str_mv |
10.1590/SciELOPreprints.681 |
dc.language.iso.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://preprints.scielo.org/index.php/scielo/article/view/681/899 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
SciELO Preprints SciELO Preprints SciELO Preprints |
publisher.none.fl_str_mv |
SciELO Preprints SciELO Preprints SciELO Preprints |
dc.source.none.fl_str_mv |
reponame:SciELO Preprints instname:SciELO instacron:SCI |
instname_str |
SciELO |
instacron_str |
SCI |
institution |
SCI |
reponame_str |
SciELO Preprints |
collection |
SciELO Preprints |
repository.name.fl_str_mv |
SciELO Preprints - SciELO |
repository.mail.fl_str_mv |
scielo.submission@scielo.org |
_version_ |
1797047818489167872 |